Formulation and Evaluation of Piperazine Citrate Medicated Candy for Pediatric Drug Delivery
Pediatric drug delivery is a significant challenge in pharmaceutical formulation development because children often experience difficulty swallowing conventional dosage forms such as tablets and capsules. Poor palatability and unpleasant taste may further reduce patient compliance and affect the successful administration of medication. Medicated candy represents a promising alternative dosage form that combines acceptable taste, convenience, and ease of administration. The present review focuses on the formulation and evaluation of Piperazine citrate medicated candy as a potential drug delivery system for pediatric patients. Piperazine citrate is an anthelmintic agent used in the treatment of certain intestinal worm infections. Incorporating this drug into a palatable candy formulation may improve acceptability and encourage better medication compliance among children. The formulation involves the selection of suitable excipients, including sweetening agents, flavouring agents, and a suitable candy base, while maintaining drug stability and uniformity. Various evaluation parameters, such as appearance, weight variation, hardness, moisture content, drug content uniformity, in-vitro drug release, taste acceptability, and stability studies, are important for assessing the quality of the developed formulation. Special attention should be given to dose accuracy, pediatric safety, and appropriate packaging to prevent accidental consumption. This review highlights the potential advantages, formulation considerations, evaluation methods, and challenges associated with Piperazine citrate medicated candy. Overall, this dosage form may offer a patient-friendly approach to pediatric anthelmintic therapy; however, its effectiveness, safety, stability, and suitability require systematic investigation and appropriate pharmaceutical evaluation before clinical use.
Authors
- Prajkta Annasaheb Kate (ORCID: https://orcid.org/0009-0001-5737-288X)
- Yash K. Tambe
- Dr. Sampat D. Navale
Institutions
- Dr. Babasaheb Ambedkar Technological University (IN)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.5281/zenodo.24217156
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00